Discovery of 3-aryloxy-lactam analogs as potent androgen receptor full antagonists for treating castration resistant prostate cancer

A series of novel, non-steroidal AR antagonists were discovered through HTS. ADME profile was also improved by designing more ligand-efficient molecules.